Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Resveratrol
Therapeutic Area : Neurology
Study Phase : Undisclosed
Recipient : Northumbria University
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Resveratrol is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Cognition Disorders.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
March 19, 2020
Lead Product(s) : Resveratrol
Therapeutic Area : Neurology
Highest Development Status : Undisclosed
Recipient : Northumbria University
Deal Size : Inapplicable
Deal Type : Inapplicable